Italia Markets closed

Merck & Co., Inc. (MRK)

NYSE - Nasdaq Prezzo in tempo reale. Valuta in USD.
Aggiungi a portafoglio
77,09-3,16 (-3,94%)
Alla chiusura: 3:59PM EST

77,12 0,03 (0,04%)
Dopo ore: 4:01PM EST

Merck & Co., Inc.

2000 Galloping Hill Road
Kenilworth, NJ 07033
United States
908 740 4000
http://www.merck.com

Settore/iHealthcare
SettoreDrug Manufacturers—General
Impiegati a tempo pieno71.000

Figure dirigenziali chiave

NomeTitoloRetribuzioneEsercitateAnno di nascita
Mr. Kenneth C. FrazierChairman, Pres & CEO6,64M28,28M1955
Mr. Robert M. DavisExec. VP of Global Services & CFO3,29M10,18M1967
Ms. Jennifer L. ZacharyExec. VP, Gen. Counsel & Corp. Sec.2,47MN/D1978
Mr. Sanat ChattopadhyayExec. VP & Pres of Merck Manufacturing Division2,01M2,98M1960
Mr. David Michael WilliamsChief Information & Digital OfficerN/DN/DN/D
Mr. Peter Dannenbaum CFAVP of Investor RelationsN/DN/DN/D
Michael W. FlemingSr. VP and Chief Ethics & Compliance OfficerN/DN/D1959
Ms. Jennifer MauerVP of Global CommunicationsN/DN/DN/D
Mr. Michael T. NallyChief Marketing Officer & Exec. VPN/DN/D1976
Mr. Steven C. MizellExec. VP & Chief HR OfficerN/DN/D1960
Gli importi risalgono al giorno 31 dicembre 2019 e i valori di compensazione riguardano l'anno fiscale che si chiude a tale data. La retribuzione include salari, bonus ecc. "Esercitate" è il valore delle opzioni esercitate durante l'anno fiscale. Valuta in USD.

Descrizione

Merck & Co., Inc. provides healthcare solutions worldwide. The company offers therapeutic for cardiovascular, type 2 diabetes, chronic hepatitis C virus, HIV-1 infection, intra-abdominal, fungal infection, insomnia, and inflammatory diseases; neuromuscular blocking agents; cholesterol modifying medicines; and anti-bacterial and vaginal contraceptive products. It provides products to prevent chemotherapy-induced and post-operative nausea and vomiting; treat non-small-cell lung, ovarian and breast, esophageal, thyroid, cervical, and brain cancers; and prevent diseases caused by human papillomavirus, as well as vaccines for measles, mumps, rubella, varicella, shingles, rotavirus gastroenteritis, and pneumococcal diseases. In addition, the company offers drugs for hepatocellular and merkel cell carcinoma; antibiotic and anti-inflammatory drugs for infectious and respiratory diseases, fertility disorders, and pneumonia in cattle, bovine, and swine; vaccines for poultry; parasiticides for sea lice in salmon; and antibiotics and vaccines for fish. Further, it provides companion animal products; diabetes mellitus treatment and anthelmintic products for dogs and cats; products to treat fleas, ticks, mosquitoes, and sandflies; horse fertility management products for swine; and dog, cat, and horse vaccines. Additionally, the company offers services and solutions that focus on engagement, clinical, and health analytics. Merck & Co., Inc. has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Almac Discovery Ltd.; Skyhawk Therapeutics, Inc.; Ridgeback Biotherapeutics; Shanghai Junshi Biosciences Co., Ltd.; FUJIFILM Corporation; Intec Pharma Ltd.; Transcenta Holding Ltd.; and Janux Therapeutics, Inc. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers; and physicians and physician distributors, veterinarians, and animal producers. The company was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Governance aziendale

L'ISS Governance QualityScore di Merck & Co., Inc. al 22 gennaio 2021 è 2. I criteri di valutazione fondamentali sono revisione: 1; Consiglio di Amministrazione: 7; diritti degli azionisti: 2; retribuzione: 2.

Punteggi di corporate governance forniti da Institutional Shareholder Services (ISS). I punteggi indicano il rango decile relativo all’indice o alla regione. Un punteggio di decile pari a 1 indica un governance risk più basso, mentre un punteggio di 10 indica un governance risk più alto.